CTLA4 and neoplasm: In tumor, we found that the expression of tumor ploidy, CTLA4, PD1, and B7-1 was significantly higher in patients with recurrence versus those without recurrence (Figure 5E), but there was no statistical significance found in immune score (Supplementary Figure 8H).